Fact CheckerSign in

NCT01793103Active, not recruiting

Brigham and Women's Rheumatoid Arthritis Sequential Study

Source: ClinicalTrials.gov · Last updated 26 Sept 2025

Brief summary (registry, in English)

The goal of the present study is to establish a prospective observational cohort of Rheumatoid Arthritis patients in order to 1. Determine and validate biomarkers that predict drug response and toxicity in RA. 2. Determine and validate biomarkers that predict disease activity and prognosis in RA. 3. Evaluate the natural history of treated RA in terms of its clinical, functional and economic outcomes.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
1598 (actual)
First submitted
14 Feb 2013
Start date
Mar 2003
Primary completion date
Mar 2028
Lead sponsor
Brigham and Women's Hospital
NCT number
NCT01793103

What you commit to

  • Study type: Observational
  • Participants enrolled: 1598
  • From Mar 2003 to the primary completion date, Mar 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • have a history of SLE or Psoriasis

Age

  • less than 18 years of age

Other

  • do not have a diagnosis of RA

Who the study is looking for

  • Are 18 years of age or older;
  • Are a patient registered at the R.B.Brigham Arthritis Center.
  • Have, at the time of enrollment a diagnosis of RA made by a board certified rheumatologist.
  • Are able and willing to provide informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Brigham and Women's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.